SCHEMBL22729949

SCHEMBL22729949

Cc1cc(-c2ccc3nnn(Cc4cccc5cccnc45)c3n2)ccc1C(=O)NOC[C@H](C)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 5/20 0.35
SLC22A12 Q96S37 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
KCNH2 Q12809 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
ADORA2A P29274 4/20 0.34
ADORA1 P30542 4/20 0.34
AKT1 P31749 3/20 0.33
KDR P35968 3/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22729912 1.00 MET (0.35) METSLC22A12PSEN1PSEN2KCNH2
SCHEMBL22729947 0.92 MET (0.36) METSLC22A12PSEN1PSEN2KCNH2
SCHEMBL15288682 0.87 MET (0.45) MET
SCHEMBL15288686 0.87 MET (0.45) MET
SCHEMBL15288789 0.87 MET (0.45) MET
SCHEMBL22729940 0.85 MET (0.35) METSLC22A12PSEN1PSEN2KCNH2
SCHEMBL20530360 0.85 SLC22A12 (0.40) METSLC22A12PSEN1PSEN2KCNH2
SCHEMBL20530361 0.81 MET (0.40) METKCNH2
SCHEMBL22729926 0.81 MET (0.36) METSLC22A12PSEN1PSEN2KCNH2
SCHEMBL20530355 0.80 RIPK1 (0.43) METADORA2AADORA1HDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2831073-B1 NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES RHIZEN PHARMACEUTICALS S A (CH) 2020-12-09 EP claimed